Oric Pharmaceuticals, Inc. ORIC 深 滬
等待開盤 11-04 09:30:00 美东时间
9.59
+0.520
+5.73%
華盛通- 最 高10.00
- 今 開9.17
- 成交量 355.56万股
- 最 低 9.17
- 昨 收 9.07
- 總市值 9.94亿
- 52周最高 14.68
- 市盈率 靜 --
- 換手率 3.43%
- 52周最低 7.23
- 委 比 -15.15%
- 總股本 1.04亿
- 歷史最高 40.81
- 量 比 1.51
- 振 幅 9.15%
- 歷史最低 2.36
- 每 手 1
- 風險率 1.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101.01%！Stifel上调ORIC Pharmaceuticals目标价至18美元，维持"买入"评级
今日重点评级关注：Stifel：维持ORIC Pharmaceuticals"买入"评级，目标价从14美元升至18美元；花旗：维持Liberty Energy"买入"评级，目标价从27.5美元升至28美元
10-27 12:30
Stifel Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $18
Stifel analyst Laura Prendergast maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $14 to $18.
10-27 00:44
美股大行评级 | 潜在涨幅325.53%！HC Wainwright维持Alector"买入"评级，目标价上调至8美元
今日重点评级关注：HC Wainwright & Co.：维持Alector"买入"评级，目标价从5美元升至8美元；摩根大通：维持ORIC Pharmaceuticals"超配"评级，目标价从23美元升至26美元
10-15 12:36
Meta To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. RBC Capital raised the price target for Albertsons Companies Inc (NYSE:ACI) from $13 to $16. RBC Capital analy...
10-14 21:20
JP Morgan Maintains Overweight on ORIC Pharmaceuticals, Raises Price Target to $26
JP Morgan analyst Anupam Rama maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Overweight and raises the price target from $23 to $26.
10-14 20:57
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级
今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元
10-06 16:45
Leerink Partners Initiates Coverage On ORIC Pharmaceuticals with Outperform Rating, Announces Price Target of $26
Leerink Partners analyst Asthika Goonewardene initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Outperform rating and announces Price Target of $26.
10-05 20:57
美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
BTIG Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $26
BTIG analyst Jeet Mukherjee initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $26.
09-23 18:36
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
